ONPATTRO
Google image searchProduct monograph
Active ingredient
patisiran (patisiran sodium), 2 MG/ML
DIN: 02489252
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: LIPID COMPLEX
Schedule: Prescription
Company: ALNYLAM NETHERLANDS B.V.
Date: 25-JUL-2019
ATC:
- N07 — OTHER NERVOUS SYSTEM DRUGS (ATC, ATC/DDD, )
- N07X — OTHER NERVOUS SYSTEM DRUGS (ATC, ATC/DDD)
- N07XX — Other nervous system drugs (ATC, ATC/DDD)
- N07XX12 — PATISIRAN (ATC/DDD)
